Who Pays for an Expensive Prostate Cancer Drug? - CBS Evening News - CBS News
For tens of thousands of prostate cancer victims, Provenge equals hope. To make the drug, the patient's own blood cells are drawn and then exposed in a lab to a protein that mimics the cancer.
They're then returned to the patient essentially supercharged to attack the cancer. The issue is that it costs $93,000 per patient for four extra months of survival.
No comments:
Post a Comment